US Patent Issued to GEn1E Lifesciences on Oct. 6 for "P38alpha mitogen-activated protein kinase inhibitors" (California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,184, issued on Oct. 6, was assigned to GEn1E Lifesciences Inc. (Palo Alto, Calif.).

"P38alpha mitogen-activated protein kinase inhibitors" was invented by Adam Galan (Alameda, Calif.), Wendy Luo (Sunnyvale, Calif.) and Ritu Lal (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are p38Alpha mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38Alpha mitogen-activated protein kinase inhibitors."

The patent was filed on Jan. 29, 2024, under Application No. 18/425,036.

*For further information, including images, charts and tables, please visit: http://p...